HIA
ROIV icon

HFM Investment Advisors’s Roivant Sciences ROIV Stock Holding History

HFM Investment Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02K Buy
57
+24
+73% +$709 ﹤0.01% 453
2026
Q1 		$914 Buy
33
+7
+27% +$180 ﹤0.01% 445
2025
Q4 		$565 Buy
26
+11
+73% +$217 ﹤0.01% 671
2025
Q3 		$227 Buy
+15
New +$186 ﹤0.01% 959

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HFM Investment Advisors's ROIV Position: Q2 2026 in Review

HFM Investment Advisors increased its Roivant Sciences (ROIV) stake by 73% in Q2 2026, buying an estimated $709 and bringing the position to 57 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

HFM Investment Advisors first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • HFM Investment Advisors held 57 shares of Roivant Sciences worth $2.02K as of Q2 2026.
  • HFM Investment Advisors bought 24 Roivant Sciences shares in Q2 2026, an estimated $709.
  • Roivant Sciences made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #453 holding.
  • HFM Investment Advisors first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.